ReviewArchives of medical science : AMS2025

Cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early oestrogen receptor-positive breast cancer: a systematic review.

Ying X Gue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.